Last week wrapped up our annual Stansberry Research Conference & Alliance Meeting.

This year we stayed at the Aria Resort & Casino, in the heart of the Las Vegas Strip. The conference – a three-day event where our editors, guest speakers, staff, and subscribers all gather to talk about the biggest themes in the economy and market – was a blast.

It's truly one of my favorite events of the year... I love meeting subscribers and hearing different viewpoints on the markets.

Last Wednesday was Alliance Day at the conference, where our staff shared our best ideas with Alliance members. One highlight, for me, was the "Bull, Bear, or B.S." panel.

It was hosted by Matt Weinschenk, my longtime analyst and Stansberry's current director of research. The panel brought together some of our company's top editors to debate various subjects and decide if we're bullish, bearish, or calling B.S. on them. We talked about everything from AI to housing to even the midterm elections.

I'm going to focus on the midterms in today's issue because, well, anytime politics are brought up, there's a wide range of opinions and emotions.

Interestingly, many editors and analysts on the panel said the midterms didn't factor into their investment strategy. And for good reason...

When it comes to managing your wealth, letting political opinions dictate your portfolio is one of the fastest ways to shoot yourself in the foot. If you're a Republican, you'd miss out on a lot of gains if you weren't invested during the blue years... and vice versa.

While elections spark strong emotions, the truth is that the market doesn't care all that much about red or blue. It mostly cares about things like corporate earnings and interest rates.

But to say midterms are total B.S. would be incorrect, too.

And that's because the market hates uncertainty.

Heading into a midterm election, investors frequently contend with policy debates, shifting legislative control, and proposed changes to tax laws or regulations. This ambiguity tends to hurt valuations and keep capital on the sidelines during the spring and summer months.

Then, as polling data clarifies in October and the election results solidify in early November, market participants get a clearer picture of the upcoming policy landscape. Historically, regardless of which party wins congressional seats, markets can focus again on company profits, business spending, and the broader economy once the political uncertainty is over.

And almost a century of data tells us to expect a strong fourth quarter...

Just take a look at this chart tracking the performance of the S&P 500 Index across the four-year presidential election cycle since 1930...

While the S&P 500 gains an average of 2.9% in the fourth quarter across all years, that figure nearly doubles to 5.6% during midterm-election years.

In fact, October and November are historically the two strongest months of the entire midterm calendar. Since 1930, these two months have resulted in positive returns nearly 70% of the time in midterm years.

It's true that political headlines will always provoke strong reactions and debates. But investors need to separate emotional noise from market reality if they want to make money.

While we can't predict exactly what will happen this year, history tells us that stocks are likely to soar over the next couple months as the election uncertainty clears.

Brett Eversole, my colleague and the editor of True Wealth, knows there is money to be made in the markets as this election cycle continues. He notes that the third year in an election cycle is where the biggest gains are...

Not only that, but Brett believes we're now entering Phase 2 of the AI boom – which could dramatically change the outlook for the entire AI trade. Put simply, Brett says that this next phase could lead to some huge winners and losers as this bull market continues.

Between the midterm elections and AI's Phase 2, there are plenty of opportunities ahead for investors who know where to look. Brett can help with that. Over the past decade, his annualized returns have beaten the average hedge fund's by nearly 4 times.

And now, he can help you find the AI companies with the biggest potential to soar... while the crowd is still looking elsewhere.

Brett covered all the details of the current opportunities in the market in a recent video presentation. Today is the last day to check it out – and get two free recommendations (one stock Brett likes and one he suggests you avoid). Click here for all the details.

What We're Reading...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
October 7, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top